202 related articles for article (PubMed ID: 33061808)
21. Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.
Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
J Cereb Blood Flow Metab; 2005 Feb; 25(2):267-80. PubMed ID: 15678128
[TBL] [Abstract][Full Text] [Related]
22. Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy.
Harakandi C; Nininahazwe L; Xu H; Liu B; He C; Zheng YC; Zhang H
Bioorg Chem; 2021 Nov; 116():105273. PubMed ID: 34474304
[TBL] [Abstract][Full Text] [Related]
23. USP14 Inhibition Regulates Tumorigenesis by Inducing Autophagy in Lung Cancer In Vitro.
Han KH; Kwak M; Lee TH; Park MS; Jeong IH; Kim MJ; Jin JO; Lee PC
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653087
[TBL] [Abstract][Full Text] [Related]
24. Dynamics in the p53-Mdm2 ubiquitination pathway.
Brooks CL; Gu W
Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
[TBL] [Abstract][Full Text] [Related]
25. Dual Function of USP14 Deubiquitinase in Cellular Proteasomal Activity and Autophagic Flux.
Kim E; Park S; Lee JH; Mun JY; Choi WH; Yun Y; Lee J; Kim JH; Kang MJ; Lee MJ
Cell Rep; 2018 Jul; 24(3):732-743. PubMed ID: 30021169
[TBL] [Abstract][Full Text] [Related]
26. Compensatory increase in USP14 activity accompanies impaired proteasomal proteolysis during aging.
Ponnappan S; Palmieri M; Sullivan DH; Ponnappan U
Mech Ageing Dev; 2013; 134(1-2):53-9. PubMed ID: 23291607
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation and activation of ubiquitin-specific protease-14 by Akt regulates the ubiquitin-proteasome system.
Xu D; Shan B; Lee BH; Zhu K; Zhang T; Sun H; Liu M; Shi L; Liang W; Qian L; Xiao J; Wang L; Pan L; Finley D; Yuan J
Elife; 2015 Nov; 4():e10510. PubMed ID: 26523394
[TBL] [Abstract][Full Text] [Related]
28. A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer.
Ding X; Jia X; Wang C; Xu J; Gao SJ; Lu C
Cell Death Differ; 2019 Sep; 26(9):1750-1765. PubMed ID: 30518908
[TBL] [Abstract][Full Text] [Related]
29. Post-endocytotic Deubiquitination and Degradation of the Metabotropic γ-Aminobutyric Acid Receptor by the Ubiquitin-specific Protease 14.
Lahaie N; Kralikova M; Prézeau L; Blahos J; Bouvier M
J Biol Chem; 2016 Mar; 291(13):7156-70. PubMed ID: 26817839
[TBL] [Abstract][Full Text] [Related]
30. Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy.
Birks EJ; Latif N; Enesa K; Folkvang T; Luong le A; Sarathchandra P; Khan M; Ovaa H; Terracciano CM; Barton PJ; Yacoub MH; Evans PC
Cardiovasc Res; 2008 Aug; 79(3):472-80. PubMed ID: 18375498
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion.
Lo D; Dai MS; Sun XX; Zeng SX; Lu H
J Biol Chem; 2012 Mar; 287(13):10013-10020. PubMed ID: 22318725
[TBL] [Abstract][Full Text] [Related]
32. MDM2 E3 ubiquitin ligase mediates UT-A1 urea transporter ubiquitination and degradation.
Chen G; Huang H; Fröhlich O; Yang Y; Klein JD; Price SR; Sands JM
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1528-34. PubMed ID: 18784257
[TBL] [Abstract][Full Text] [Related]
33. WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway.
Sun Y; Cao L; Sheng X; Chen J; Zhou Y; Yang C; Deng T; Ma H; Feng P; Liu J; Tan W; Ye M
Cell Death Dis; 2017 Apr; 8(4):e2743. PubMed ID: 28406480
[TBL] [Abstract][Full Text] [Related]
34. Effect of ubiquitin-proteasome system and autophagy-lysosome pathway on intracellular replication of Brucella.suis.
Dong B; Li F; Wang J; Lv S; Miao L; Guo G; Shen Z
Vet Microbiol; 2023 May; 280():109699. PubMed ID: 36812863
[TBL] [Abstract][Full Text] [Related]
35. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
[TBL] [Abstract][Full Text] [Related]
36. Targeting retinoblastoma protein for degradation by proteasomes.
Ying H; Xiao ZX
Cell Cycle; 2006 Mar; 5(5):506-8. PubMed ID: 16552188
[TBL] [Abstract][Full Text] [Related]
37. Examination of genetic and pharmacological tools to study the proteasomal deubiquitinating enzyme ubiquitin-specific protease 14 in the nervous system.
Tian T; McLean JW; Wilson JA; Wilson SM
J Neurochem; 2021 Feb; 156(3):309-323. PubMed ID: 32901953
[TBL] [Abstract][Full Text] [Related]
38. (1)H, (13)C and (15)N backbone resonance assignment for the 40.5 kDa catalytic domain of Ubiquitin Specific Protease 7 (USP7).
Di Lello P; Rougé L; Pan B; Maurer T
Biomol NMR Assign; 2016 Oct; 10(2):345-9. PubMed ID: 27386854
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of USP14 protease reduces I-κB protein levels and increases cytokine release in lung epithelial cells.
Mialki RK; Zhao J; Wei J; Mallampalli DF; Zhao Y
J Biol Chem; 2013 May; 288(22):15437-41. PubMed ID: 23615914
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin-specific protease 14 regulates c-Jun N-terminal kinase signaling at the neuromuscular junction.
Vaden JH; Bhattacharyya BJ; Chen PC; Watson JA; Marshall AG; Phillips SE; Wilson JA; King GD; Miller RJ; Wilson SM
Mol Neurodegener; 2015 Jan; 10():3. PubMed ID: 25575639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
